rom a rural coastal area of Bangladesh. Front Microbiol 2017;8:252.
Das B, Verma J, Kumar P, Ghosh A, Ramamurthy T. Antibiotic resistance in Vibrio cholerae
: Understanding the ecology of resistance genes and mechanisms. Vaccine 2019. pii: S0264-410X(19)30793-5.
Huq A, Haley BJ, Taviani E, Chen A, Hasan NA, Colwell RR. Detection, isolation, and identification of Vibrio cholerae
from the environment. Curr Protoc Microbiol 2012; Chapter 6, Unit6A.5. Sep 2006.
Ansari MQ, Pal SC. Phage typing of Vibrio cholerae
01 biotype ElT or strains. Indian J Med Res 1990;91:263-5.
Alam MT, Ray SS, Chun CN, Chowdhury ZG, Rashid MH, Madsen Beau De Rochars VE, et al
. Major shift of toxigenic V. cholerae
O1 from Ogawa to Inaba serotype isolated from clinical and environmental samples in Haiti. PLoS Negl Trop Dis 2016;10:e0005045.
Stroeher UH, Karageorgos LE, Morona R, Manning PA. Serotype conversion in Vibrio cholerae
O1. Proc Natl Acad Sci U S A 1992;89:2566-70.
Khan AI, Chowdhury F, Harris JB, Larocque RC, Faruque AS, Ryan ET, et al
. Comparison of clinical features and immunological parameters of patients with dehydrating diarrhoea infected with Inaba or Ogawa serotypes of Vibrio cholerae
O1. Scand J Infect Dis 2010;42:48-56.
Jensen MA, Faruque SM, Mekalanos JJ, Levin BR. Modeling the role of bacteriophage in the control of cholera outbreaks. Proc Natl Acad Sci U S A 2006;103:4652-7.
Nelson EJ, Chowdhury A, Harris JB, Begum YA, Chowdhury F, Khan AI, et al
. Complexity of rice-water stool from patients with Vibrio cholerae
plays a role in the transmission of infectious diarrhea. Proc Natl Acad Sci U S A 2007;104:19091-6.
Furfaro LL, Payne MS, Chang BJ. Bacteriophage therapy: Clinical trials and regulatory hurdles. Front Cell Infect Microbiol 2018;8:376.
Vahedi A, Soltan Dallal MM, Douraghi M, Nikkhahi F, Rajabi Z, Yousefi M, et al
. Isolation and identification of specific bacteriophage against enteropathogenic Escherichia coli
(EPEC) andin vitro
characterization of bacteriophage. FEMS Microbiol Lett 2018;365. pii: fny136.
Chadha P, Katare OP, Chhibber S. Liposome loaded phage cocktail: Enhanced therapeutic potential in resolving Klebsiella pneumoniae
mediated burn wound infections. Burns 2017;43:1532-43.
Harper DR. Criteria for selecting suitable infectious diseases for phage therapy. Viruses 2018;10 (4): 177.
Sarker SA, Sultana S, Reuteler G, Moine D, Descombes P, Charton F, et al
. Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: A randomized trial in children from Bangladesh. EBioMedicine 2016;4:124-37.
Morison J, Vardon AC. A cholera and dysentery bacteriophage. Indian J Med Res 1929;17:48-54.
Morison J. Bacteriophage in the Treatment and Prevention of Cholera. London: H. K: Lewis and Co.; 1932. p. 12-3.
Summers WC. Cholera and Plague in India: The Bacteriophage Inquiry of 1927–1936. J Hist Med Allied Sci, 1993; 48(3):275–301.
Kuchment A, editor. They're not a panacea: Phage therapy in the Soviet Union and Georgia. In: The Forgotten Cure: The Past and Future of Phage Therapy. New York, USA: Springer; 2012. p. 53-62.
Dengo-Baloi LC, Semá-Baltazar CA, Manhique LV, Chitio JE, Inguane DL, Langa JP. Antibiotics resistance in El Tor Vibrio cholerae
01 isolated during cholera outbreaks in Mozambique from 2012 to 2015. PLoS One 2017;12:e0181496.
Torane V, Kuyare S, Nataraj G, Mehta P, Dutta S, Sarkar B. Phenotypic and antibiogram pattern of V. cholerae
isolates from a tertiary care hospital in Mumbai during 2004-2013: A retrospective cross-sectional study. BMJ Open 2016;6:e012638.
Jaiswal A, Koley H, Ghosh A, Palit A, Sarkar B. Efficacy of cocktail phage therapy in treating Vibrio cholerae
infection in rabbit model. Microbes Infect 2013;15:152-6.
Chan BK, Abedon ST, Loc-Carrillo C. Phage cocktails and the future of phage therapy. Future Microbiol 2013;8:769-83.
Summers WC. Cholera and plague in India: The bacteriophage inquiry of 1927-1936. J Hist Med Allied Sci 1993;48:275-301.
Nelson EJ, Harris JB, Morris JG Jr., Calderwood SB, Camilli A. Cholera transmission: The host, pathogen and bacteriophage dynamic. Na